Skip to main content
  • 280 Accesses

Abstract

Although improvements in the treatment of various gynecologic malignancies including new chemotherapies and combinations of surgery or radiation plus chemotherapy have been developed in the past few years, the most significant impact on mortality from cancer has been achieved by prevention and early detection of this disease. If we examine the incidence of gynecologic cancers and the death rate from these malignancies, it can be seen that cervical and ovarian cancers are the most significant; therefore, this lecture will address those two malignancies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  1. Bernstein SJ, Sanchez-Ramos L, Ndubisi B (2001) Liquid-based cervical cytologic smear study and conventional Papanicolaou smears: A metaanalysis of prospective studies comparing cytologic diagnosis and sample adequacy. Am J Obstet Gynecol 185: 308–317

    Article  PubMed  CAS  Google Scholar 

  2. Wilbur DC, Prey MU, Miller WM, Pawlick GF, Colgan TJ (1998) The autopap system for primary screening in cervical cytology. Acta Cytologica 42: 214–220

    Article  PubMed  CAS  Google Scholar 

  3. Denny L, Kuhn L, Pollack A, Wainwright H, Wright, TC, Jr (2000) Evaluation of alternative methods of cervical cancer screening for resource-poor settings. Cancer 89: 826–833

    Article  PubMed  CAS  Google Scholar 

  4. Schiffman M, Herrero R, Hildesheim A, Sherman ME, Bratti M, Wacholder S, et al (2000) HPV DNA testing in cervical cancer screening: Results from women in a high-risk province of Costa Rica. JAMA 283: 87–93

    Article  PubMed  CAS  Google Scholar 

  5. van Nagell JR, Jr, DePriest PD, Reedy MB, Gallion HH, Ueland FR, Pavlik EJ, Kryscio RJ (2000) The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer. Gynecol Oncol 7: 350–356

    Article  Google Scholar 

  6. Petricoin EF, III, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, et al (2002) Use of prot-eomic patterns in serum to identify ovarian cancer. Lancet 359: 572–577

    Article  PubMed  CAS  Google Scholar 

  7. Walker GR, Schlesselman JJ, Ness RB (2002) Family history of cancer, oral contraceptive use, and ovarian cancer risk. Am J Obstet Gynecol 186: 8–14

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Jones, H.W. (2003). Prevention and Early Detection of Gynecologic Cancer. In: Bender, H.G., Dall, P. (eds) 54. Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18257-0_35

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-18257-0_35

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62125-3

  • Online ISBN: 978-3-642-18257-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics